 Peter Dempsey
Concepts (649)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 25 | 2015 | 58 | 3.060 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 72 | 2.210 |
Why?
| | Membrane Proteins | 19 | 2022 | 1016 | 1.750 |
Why?
| | Intestines | 7 | 2023 | 325 | 1.590 |
Why?
| | ADAM10 Protein | 15 | 2022 | 28 | 1.420 |
Why?
| | Stem Cell Niche | 3 | 2021 | 41 | 1.380 |
Why?
| | Cell Plasticity | 2 | 2021 | 23 | 1.370 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 53 | 1.320 |
Why?
| | ErbB Receptors | 27 | 2018 | 554 | 1.310 |
Why?
| | Receptors, Notch | 3 | 2020 | 83 | 1.200 |
Why?
| | Metalloendopeptidases | 13 | 2017 | 54 | 1.190 |
Why?
| | Breast Neoplasms | 27 | 2014 | 1846 | 1.180 |
Why?
| | Intercellular Signaling Peptides and Proteins | 14 | 2013 | 347 | 1.110 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 11 | 0.970 |
Why?
| | Protein Precursors | 7 | 2010 | 119 | 0.950 |
Why?
| | Integrases | 2 | 2018 | 116 | 0.920 |
Why?
| | Mammography | 17 | 2010 | 101 | 0.880 |
Why?
| | Organoids | 8 | 2023 | 74 | 0.870 |
Why?
| | Breast | 11 | 2010 | 138 | 0.800 |
Why?
| | Intestinal Mucosa | 8 | 2023 | 532 | 0.770 |
Why?
| | Paneth Cells | 3 | 2018 | 17 | 0.760 |
Why?
| | Biopsy, Needle | 8 | 2010 | 180 | 0.730 |
Why?
| | ADAM17 Protein | 17 | 2022 | 30 | 0.670 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 24 | 0.670 |
Why?
| | alpha-Defensins | 1 | 2018 | 11 | 0.630 |
Why?
| | Signal Transduction | 25 | 2018 | 4501 | 0.630 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 27 | 0.620 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 160 | 0.560 |
Why?
| | Carcinogenesis | 2 | 2018 | 175 | 0.550 |
Why?
| | Proteolysis | 1 | 2017 | 142 | 0.540 |
Why?
| | Breast Diseases | 4 | 2010 | 20 | 0.490 |
Why?
| | Animals | 66 | 2023 | 31570 | 0.490 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 85 | 0.490 |
Why?
| | Mice | 43 | 2023 | 14847 | 0.480 |
Why?
| | Regeneration | 3 | 2021 | 158 | 0.470 |
Why?
| | Cell Membrane | 9 | 2017 | 670 | 0.460 |
Why?
| | Epithelial Cells | 11 | 2023 | 946 | 0.460 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 44 | 0.440 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1128 | 0.440 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 169 | 0.430 |
Why?
| | Metalloproteases | 6 | 2017 | 37 | 0.430 |
Why?
| | Neoplasms | 6 | 2017 | 2089 | 0.420 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 52 | 0.420 |
Why?
| | Stem Cells | 3 | 2020 | 541 | 0.390 |
Why?
| | Radiology | 1 | 2014 | 137 | 0.390 |
Why?
| | Cell Line | 19 | 2014 | 2629 | 0.380 |
Why?
| | Cell Proliferation | 10 | 2021 | 2173 | 0.370 |
Why?
| | Mass Screening | 5 | 2009 | 979 | 0.350 |
Why?
| | Gene Targeting | 1 | 2010 | 75 | 0.350 |
Why?
| | Mice, Knockout | 12 | 2015 | 2563 | 0.340 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 44 | 0.330 |
Why?
| | Tamoxifen | 1 | 2010 | 190 | 0.330 |
Why?
| | Inflammation | 5 | 2019 | 2465 | 0.320 |
Why?
| | Terminology as Topic | 2 | 2007 | 187 | 0.310 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.300 |
Why?
| | Stomach | 3 | 2009 | 102 | 0.300 |
Why?
| | Thinness | 1 | 2008 | 87 | 0.290 |
Why?
| | Apoptosis | 10 | 2021 | 2349 | 0.290 |
Why?
| | Growth Substances | 6 | 1999 | 138 | 0.270 |
Why?
| | Humans | 80 | 2021 | 114078 | 0.270 |
Why?
| | Homeostasis | 2 | 2021 | 570 | 0.270 |
Why?
| | Peptide Fragments | 2 | 2010 | 665 | 0.270 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 317 | 0.270 |
Why?
| | Hyperplasia | 3 | 2018 | 163 | 0.260 |
Why?
| | Glycoproteins | 8 | 2008 | 304 | 0.260 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.260 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2008 | 409 | 0.260 |
Why?
| | Transcriptional Activation | 6 | 2013 | 337 | 0.250 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 1981 | 0.250 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 295 | 0.240 |
Why?
| | Cell Lineage | 2 | 2018 | 308 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 6 | 2007 | 399 | 0.230 |
Why?
| | Allyl Compounds | 2 | 2022 | 15 | 0.220 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 796 | 0.220 |
Why?
| | beta Catenin | 2 | 2023 | 218 | 0.220 |
Why?
| | Energy Metabolism | 1 | 2008 | 727 | 0.210 |
Why?
| | Cell Differentiation | 7 | 2014 | 1696 | 0.210 |
Why?
| | Sulfides | 2 | 2022 | 93 | 0.210 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4682 | 0.210 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2783 | 0.200 |
Why?
| | Mice, Transgenic | 11 | 2020 | 1947 | 0.200 |
Why?
| | Betacellulin | 5 | 2010 | 6 | 0.200 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 743 | 0.200 |
Why?
| | Calcium | 5 | 2010 | 1089 | 0.190 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 97 | 0.190 |
Why?
| | Dogs | 7 | 2011 | 331 | 0.190 |
Why?
| | Female | 40 | 2021 | 59347 | 0.190 |
Why?
| | Ultrasonography | 8 | 2009 | 635 | 0.190 |
Why?
| | Microscopy | 1 | 2022 | 125 | 0.180 |
Why?
| | Angiotensin II | 3 | 2008 | 86 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 47 | 0.180 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 18 | 0.170 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1624 | 0.170 |
Why?
| | Taste Buds | 1 | 2023 | 208 | 0.170 |
Why?
| | Doxorubicin | 3 | 2018 | 286 | 0.170 |
Why?
| | Cell Movement | 4 | 2021 | 863 | 0.170 |
Why?
| | Colitis | 2 | 2019 | 223 | 0.170 |
Why?
| | Photolysis | 1 | 2020 | 79 | 0.170 |
Why?
| | Antiporters | 1 | 2019 | 18 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 128 | 0.170 |
Why?
| | Cell Survival | 2 | 2014 | 1014 | 0.170 |
Why?
| | Gastric Mucosa | 7 | 2009 | 46 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 167 | 0.160 |
Why?
| | Colon | 3 | 2017 | 232 | 0.160 |
Why?
| | History, 21st Century | 2 | 2014 | 160 | 0.160 |
Why?
| | History, 20th Century | 2 | 2014 | 265 | 0.160 |
Why?
| | Gene Deletion | 2 | 2018 | 356 | 0.160 |
Why?
| | Cell Dedifferentiation | 1 | 2018 | 28 | 0.160 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 18 | 0.160 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 17 | 0.160 |
Why?
| | Acidosis | 1 | 2019 | 86 | 0.160 |
Why?
| | T-Lymphocytes | 4 | 2013 | 1735 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 452 | 0.150 |
Why?
| | Mitosis | 2 | 2018 | 164 | 0.150 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2021 | 209 | 0.150 |
Why?
| | Clone Cells | 1 | 2018 | 247 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 176 | 0.150 |
Why?
| | Ligands | 8 | 2022 | 556 | 0.150 |
Why?
| | Atrophy | 2 | 2015 | 152 | 0.150 |
Why?
| | Leptin | 2 | 2010 | 210 | 0.150 |
Why?
| | Cells, Cultured | 15 | 2019 | 3862 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 1875 | 0.140 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 172 | 0.140 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 36 | 0.140 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 60 | 0.140 |
Why?
| | Neutrophils | 2 | 2019 | 1089 | 0.140 |
Why?
| | Goblet Cells | 2 | 2014 | 16 | 0.140 |
Why?
| | Hydrogels | 2 | 2022 | 573 | 0.140 |
Why?
| | Cell Polarity | 5 | 2003 | 131 | 0.140 |
Why?
| | Keratinocytes | 6 | 2010 | 215 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2022 | 677 | 0.140 |
Why?
| | Adenoma | 1 | 2018 | 187 | 0.140 |
Why?
| | Cytokines | 2 | 2015 | 1824 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3039 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 615 | 0.130 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2322 | 0.130 |
Why?
| | Base Sequence | 6 | 2011 | 2114 | 0.130 |
Why?
| | Receptor, ErbB-2 | 3 | 2007 | 300 | 0.130 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1690 | 0.130 |
Why?
| | Alleles | 1 | 2018 | 789 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 236 | 0.130 |
Why?
| | Antibodies, Monoclonal | 7 | 2000 | 1257 | 0.130 |
Why?
| | Time Factors | 6 | 2014 | 6077 | 0.130 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 2 | 0.130 |
Why?
| | Intestine, Small | 2 | 2018 | 121 | 0.130 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 98 | 0.120 |
Why?
| | Phenotype | 4 | 2014 | 2784 | 0.120 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 59 | 0.120 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 14 | 0.120 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 54 | 0.120 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 5 | 0.120 |
Why?
| | B-Lymphocytes | 3 | 2010 | 763 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2014 | 24 | 0.120 |
Why?
| | Kidney | 4 | 2000 | 1181 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 924 | 0.110 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1162 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2018 | 673 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 721 | 0.110 |
Why?
| | Solubility | 3 | 2020 | 223 | 0.110 |
Why?
| | ROC Curve | 4 | 2008 | 441 | 0.110 |
Why?
| | Anesthesia, Local | 1 | 1993 | 14 | 0.110 |
Why?
| | Cell Nucleus | 3 | 2018 | 552 | 0.110 |
Why?
| | Hydrolysis | 4 | 2010 | 173 | 0.110 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.110 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1331 | 0.110 |
Why?
| | Cadherins | 1 | 2014 | 175 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2014 | 113 | 0.110 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 845 | 0.110 |
Why?
| | Probiotics | 1 | 2013 | 48 | 0.100 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 284 | 0.100 |
Why?
| | Protease Inhibitors | 3 | 2012 | 96 | 0.100 |
Why?
| | Skin | 3 | 2010 | 653 | 0.100 |
Why?
| | CD3 Complex | 1 | 2013 | 92 | 0.100 |
Why?
| | Reproducibility of Results | 5 | 2020 | 2764 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 285 | 0.100 |
Why?
| | Protein Kinase C | 4 | 2003 | 271 | 0.100 |
Why?
| | Macrophages | 2 | 2017 | 1259 | 0.100 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 120 | 0.100 |
Why?
| | Blotting, Western | 4 | 2008 | 1143 | 0.100 |
Why?
| | Cell Division | 7 | 2004 | 754 | 0.100 |
Why?
| | EGF Family of Proteins | 6 | 2008 | 15 | 0.100 |
Why?
| | Amphiregulin | 6 | 2008 | 21 | 0.100 |
Why?
| | Extracellular Matrix | 3 | 2022 | 436 | 0.090 |
Why?
| | Genes, ras | 3 | 1998 | 91 | 0.090 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 69 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 388 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 65 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 271 | 0.090 |
Why?
| | Galactosides | 1 | 2010 | 3 | 0.090 |
Why?
| | Recovery of Function | 1 | 2014 | 573 | 0.090 |
Why?
| | Presenilin-2 | 1 | 2010 | 3 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 39 | 0.090 |
Why?
| | Lipoylation | 1 | 2010 | 16 | 0.090 |
Why?
| | Crosses, Genetic | 1 | 2010 | 136 | 0.090 |
Why?
| | Presenilin-1 | 1 | 2010 | 27 | 0.090 |
Why?
| | Male | 14 | 2017 | 55418 | 0.090 |
Why?
| | Peptides | 1 | 1995 | 847 | 0.090 |
Why?
| | Adult | 16 | 2010 | 30394 | 0.090 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 288 | 0.090 |
Why?
| | Receptors, IgE | 1 | 2010 | 40 | 0.080 |
Why?
| | Transfection | 6 | 2006 | 863 | 0.080 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 30 | 0.080 |
Why?
| | Hair | 1 | 2010 | 65 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2010 | 256 | 0.080 |
Why?
| | Antigens, CD | 3 | 2007 | 440 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1144 | 0.080 |
Why?
| | Radiography | 3 | 2014 | 803 | 0.080 |
Why?
| | Middle Aged | 14 | 2007 | 26620 | 0.080 |
Why?
| | Kinetics | 4 | 2005 | 1547 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2010 | 766 | 0.080 |
Why?
| | Calcinosis | 2 | 2006 | 239 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2009 | 25 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2018 | 2699 | 0.080 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 15 | 0.080 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 13 | 0.080 |
Why?
| | Fats | 1 | 2008 | 10 | 0.080 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 298 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1356 | 0.080 |
Why?
| | Disintegrins | 2 | 2007 | 5 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2017 | 589 | 0.070 |
Why?
| | Swine | 1 | 2010 | 687 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2013 | 735 | 0.070 |
Why?
| | Ion Channels | 1 | 2008 | 121 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 186 | 0.070 |
Why?
| | Enzyme Precursors | 1 | 2007 | 15 | 0.070 |
Why?
| | Isoenzymes | 2 | 2000 | 283 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2013 | 1036 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2019 | 3499 | 0.070 |
Why?
| | Intercellular Junctions | 2 | 2000 | 33 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 33 | 0.070 |
Why?
| | Hypothalamus | 1 | 2008 | 147 | 0.070 |
Why?
| | Efficiency | 1 | 2008 | 84 | 0.070 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 592 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 305 | 0.070 |
Why?
| | Observer Variation | 1 | 2008 | 298 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 104 | 0.070 |
Why?
| | United States | 3 | 2014 | 12144 | 0.070 |
Why?
| | Adipocytes | 1 | 2008 | 188 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 307 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 213 | 0.070 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 11 | 0.070 |
Why?
| | Phosphorylation | 6 | 2013 | 1559 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 225 | 0.070 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 41 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 133 | 0.060 |
Why?
| | Tyrosine | 3 | 2008 | 210 | 0.060 |
Why?
| | Eating | 1 | 2008 | 344 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 787 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 98 | 0.060 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 319 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 7 | 0.060 |
Why?
| | RNA, Messenger | 7 | 2018 | 2550 | 0.060 |
Why?
| | Fibromatosis, Aggressive | 1 | 2005 | 17 | 0.060 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 212 | 0.060 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 104 | 0.060 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 371 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 168 | 0.060 |
Why?
| | Biological Transport | 3 | 2008 | 373 | 0.060 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 140 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 332 | 0.060 |
Why?
| | Ion Transport | 1 | 2004 | 54 | 0.060 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 139 | 0.060 |
Why?
| | Neurons | 1 | 2012 | 1277 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 221 | 0.060 |
Why?
| | Gastric Acid | 2 | 1995 | 13 | 0.060 |
Why?
| | Mutation | 5 | 2010 | 3338 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2004 | 60 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 802 | 0.060 |
Why?
| | Rats | 8 | 2008 | 4913 | 0.060 |
Why?
| | Heparin | 1 | 2005 | 225 | 0.060 |
Why?
| | Motor Activity | 1 | 2008 | 635 | 0.050 |
Why?
| | Aged | 8 | 2007 | 18973 | 0.050 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 26 | 0.050 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 35 | 0.050 |
Why?
| | DNA Primers | 1 | 2004 | 508 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 269 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 224 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 684 | 0.050 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 117 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 198 | 0.050 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 73 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 67 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 197 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 350 | 0.050 |
Why?
| | Molecular Weight | 2 | 1997 | 328 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 102 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 92 | 0.050 |
Why?
| | Cytoplasm | 1 | 2003 | 255 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 192 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 295 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 300 | 0.050 |
Why?
| | Prevalence | 1 | 2008 | 2248 | 0.050 |
Why?
| | Morphogenesis | 1 | 2023 | 159 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 270 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 3315 | 0.050 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 172 | 0.050 |
Why?
| | Protein Transport | 1 | 2003 | 391 | 0.050 |
Why?
| | Milk Proteins | 2 | 1995 | 36 | 0.050 |
Why?
| | Brain | 2 | 2010 | 2355 | 0.050 |
Why?
| | Ephrin-B2 | 1 | 2021 | 35 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 694 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2013 | 771 | 0.050 |
Why?
| | Insulin | 1 | 2010 | 2080 | 0.040 |
Why?
| | Phenylalanine | 2 | 1998 | 57 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1981 | 83 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2004 | 88 | 0.040 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 10 | 0.040 |
Why?
| | Quinazolines | 2 | 2015 | 240 | 0.040 |
Why?
| | Fetal Diseases | 1 | 1981 | 146 | 0.040 |
Why?
| | Brain Diseases | 1 | 1981 | 124 | 0.040 |
Why?
| | Shear Strength | 1 | 2020 | 65 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 280 | 0.040 |
Why?
| | Thiophenes | 2 | 1998 | 108 | 0.040 |
Why?
| | Fibroblasts | 2 | 2002 | 836 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 906 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2000 | 81 | 0.040 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 20 | 0.040 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 11 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 163 | 0.040 |
Why?
| | Rheology | 1 | 2020 | 86 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 198 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 29 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 32 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 393 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 78 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 607 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 10 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 42 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 397 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 41 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 205 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2007 | 6307 | 0.040 |
Why?
| | Pain | 2 | 1993 | 701 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 13 | 0.040 |
Why?
| | Retrospective Studies | 5 | 2007 | 12521 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 108 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 695 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 61 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 372 | 0.040 |
Why?
| | Glycosylation | 1 | 1998 | 130 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2000 | 293 | 0.040 |
Why?
| | Mucin-2 | 1 | 2017 | 3 | 0.040 |
Why?
| | Adenosine | 1 | 2019 | 203 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 138 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 79 | 0.040 |
Why?
| | Cell Adhesion | 3 | 2014 | 426 | 0.040 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 31 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4404 | 0.040 |
Why?
| | Light | 1 | 2020 | 336 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 168 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 1791 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 102 | 0.040 |
Why?
| | Graft Rejection | 1 | 2000 | 511 | 0.040 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 20 | 0.040 |
Why?
| | Dipeptides | 2 | 2008 | 47 | 0.040 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1310 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2010 | 255 | 0.040 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.030 |
Why?
| | Models, Biological | 2 | 2020 | 1611 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 55 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 258 | 0.030 |
Why?
| | Extracellular Space | 1 | 1997 | 116 | 0.030 |
Why?
| | Hypertrophy | 2 | 2008 | 110 | 0.030 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 58 | 0.030 |
Why?
| | Prostaglandins | 1 | 1997 | 77 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1638 | 0.030 |
Why?
| | Spleen | 2 | 2010 | 485 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 4598 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 83 | 0.030 |
Why?
| | Foreign Bodies | 1 | 1997 | 93 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 438 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 175 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 174 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 484 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 137 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 521 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 191 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 252 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 214 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 367 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 152 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 445 | 0.030 |
Why?
| | Paclitaxel | 2 | 2006 | 190 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 282 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 960 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 66 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 93 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 108 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 49 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 670 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 63 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 42 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 2886 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 11 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 44 | 0.030 |
Why?
| | Risk Factors | 4 | 2010 | 8612 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 73 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 107 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 64 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1417 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 29 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 1993 | 26 | 0.030 |
Why?
| | Lidocaine | 1 | 1993 | 40 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 162 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 134 | 0.030 |
Why?
| | Mitogens | 1 | 1993 | 58 | 0.030 |
Why?
| | Adenoviridae | 2 | 2005 | 184 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 1 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 522 | 0.030 |
Why?
| | Hydroxamic Acids | 2 | 2006 | 80 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 1993 | 108 | 0.030 |
Why?
| | Metallothionein | 1 | 1992 | 24 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2010 | 1228 | 0.030 |
Why?
| | Stomach Diseases | 1 | 1992 | 19 | 0.030 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 21 | 0.030 |
Why?
| | Antigens | 1 | 2014 | 317 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 1977 | 430 | 0.030 |
Why?
| | Keratins | 1 | 1993 | 176 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 990 | 0.030 |
Why?
| | Contrast Media | 1 | 1975 | 347 | 0.030 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 42 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 270 | 0.020 |
Why?
| | Retroviridae | 2 | 2005 | 89 | 0.020 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 116 | 0.020 |
Why?
| | Pregnancy | 3 | 1995 | 5503 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 719 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 502 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 319 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 113 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 24 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 31 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 465 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 3 | 2003 | 2182 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 102 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 2 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 58 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 367 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 225 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 195 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 134 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 95 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 150 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 380 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 315 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 140 | 0.020 |
Why?
| | Exons | 1 | 2010 | 301 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 176 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 45 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 28 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 30 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 815 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 353 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 167 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1350 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 13 | 0.020 |
Why?
| | Epitopes | 2 | 1990 | 434 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 48 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 73 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 754 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 15 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 234 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 787 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 211 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 89 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 39 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1144 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1131 | 0.020 |
Why?
| | Laminin | 1 | 1987 | 69 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 105 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 88 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 108 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 97 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 337 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 47 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 275 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 15 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 6 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 78 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 118 | 0.020 |
Why?
| | Artifacts | 1 | 2006 | 114 | 0.020 |
Why?
| | Binding Sites | 2 | 2005 | 1166 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1986 | 146 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 237 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 132 | 0.020 |
Why?
| | Liver | 1 | 1993 | 1633 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 123 | 0.020 |
Why?
| | Organ Specificity | 1 | 1986 | 266 | 0.020 |
Why?
| | Specimen Handling | 1 | 2006 | 153 | 0.020 |
Why?
| | Ionophores | 1 | 2005 | 22 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2006 | 137 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4392 | 0.020 |
Why?
| | Lac Operon | 1 | 2005 | 44 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 733 | 0.020 |
Why?
| | Guanylate Kinases | 1 | 2005 | 13 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 1837 | 0.020 |
Why?
| | Aorta | 1 | 2008 | 388 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2005 | 65 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 384 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1996 | 136 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1003 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 142 | 0.010 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.010 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 16 | 0.010 |
Why?
| | RNA | 1 | 2010 | 806 | 0.010 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 103 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 305 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 93 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 29 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2003 | 151 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 338 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 14 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 25 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 31 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 289 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1995 | 63 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 161 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 287 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 522 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 613 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 698 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 534 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 16 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 25 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 45 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 79 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 32 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 47 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 53 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 99 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 37 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 49 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 115 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 198 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 20 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 2 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 145 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 5 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 52 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 196 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 33 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1519 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 249 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 1888 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 917 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 170 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 148 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 377 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 323 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 145 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 4 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 19 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 25 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 52 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 5 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 6 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 77 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 89 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 43 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 61 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 429 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 348 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 23 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 76 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 55 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 350 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 202 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 22 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 385 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 15 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 147 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 14 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 16 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 13 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 74 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 17 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 20 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 51 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 17811 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 72 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 80 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1612 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 164 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 7 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 192 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 10 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 541 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 285 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 2 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 19 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 4 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 42 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 24 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 11 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 16 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 24 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 21 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1579 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 133 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 80 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 193 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 507 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 105 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 82 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 22 | 0.010 |
Why?
| | Head | 1 | 1975 | 85 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 149 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1311 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 361 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 13 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 180 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 42 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 43 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 58 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 122 | 0.010 |
Why?
| | Mice, Nude | 1 | 1995 | 628 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 444 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 169 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 35 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 118 | 0.010 |
Why?
| | Movement | 1 | 1975 | 242 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 303 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 286 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 777 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 5 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 8 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 27 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 36 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 360 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 187 | 0.010 |
Why?
| | Child | 1 | 2010 | 18408 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 408 | 0.010 |
Why?
| | Piperazines | 1 | 1992 | 310 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 66 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 70 | 0.010 |
Why?
| | Disulfides | 1 | 1990 | 90 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1990 | 465 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 26 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1024 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|